Skip to content
The Nexus
DossierENTITY

left ventricular assist device

Coverage of left ventricular assist device in the Nexus archive.

Earliest in view: May 27 · 21:00 UTCMost recent: Jul 1 · 10:00 UTC
Co-mentioned in this coverage
BrioVADproduct1advanced heart failuretopic1United Statesplace1Chinaplace1biotechnology sectorstopic1BioVATtopic1induced pluripotent stem cellstopic1heart transplanttopic1heart failuretopic1STAT+organization1heart attacktopic1
Recent coverage
  • HEALTHJul 1 · 10:00 UTCSCMP CHINA
    How a ‘Chinese heart’ could get US blood pumping despite biotech decoupling

    A fully magnetically levitated heart pump developed in China, known as BrioVAD, is being used in a U.S. clinical trial to treat over 100 patients with advanced heart failure, despite political tensions driving biotech decoupling between the U.S. and China. The device, slightly larger than a table tennis ball, functions as a left ventricular assist device to circulate oxygen-rich blood.

  • HEALTHMay 27 · 21:00 UTCSTAT NEWS
    STAT+: Heart patch engineered from stem cells revved up weakened hearts

    A small study reports that heart patches engineered from induced pluripotent stem cells (BioVAT) improved heart wall thickness and pumping ability in patients with weakened hearts. The patches aim to serve as a bridge to heart transplant or LVAD implantation, with a larger trial needed to assess durability and candidacy.